Resultados de la búsqueda 91-100 of 2153 for ✍[ 텔레 : ADSFIX01 ] 블랙키워드 광고 구글상단노출 구글상위노출✍

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are benign or ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To evaluate the clinical outcomes related to IIC, including the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...